WaveMan
WaveMan · Company
GL · Globe Life Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

GL Globe Life (GL) Insider Trading, Ownership & Congress Trades

Insurance · Life insurance · CIK 0000320335
Form 144 · 5
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
349
13F, latest reported quarter
Conversions, 180 days
25
Codes C/M, not in net · $35.0M priced

What the filings say about GL

Insiders, 180 days
-$56.5M net sold
10 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-07-10
Planned sales (Form 144), 90 days
$20.3M
5 notices

Globe Life insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, GLOBE LIFE INC. insiders sold a net $56.5M of stock across 234 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
EVP - Chief Strategy Officer
SELL
2026-10-26 SECtraded 2026-10-23
14,377
$2.2M
n/a
Context
  • 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Jul 29, 2026.
  • The trade is 36.7% of the 39,141 shares held after it.
  • No other insider sold within 30 days.
  • 349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP - Chief Strategy Officer MAJORS MICHAEL CLAY sold about $2.2M of GL on Oct 23, 2026; 349 funds added in the latest 13F quarter.
EVP & Chief Investment Officer
SELL
2026-09-23 SECtraded 2026-09-22
3,344
$566.9K
-7.3%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (1 buy, 4 sales), the last on Mar 2, 2026.
  • The trade is 17.6% of the 19,039 shares held after it.
  • No other insider sold within 30 days.
  • 349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Chief Investment Officer Hensley Robert Edward sold about $566.9K of GL on Sep 22, 2026; 349 funds added in the latest 13F quarter.
EVP & Chief Investment Officer
SELL
2026-09-23 SECtraded 2026-09-22
6,656
$1.1M
-7.3%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (1 buy, 4 sales), the last on Mar 2, 2026.
  • The trade is 53.7% of the 12,383 shares held after it.
  • No other insider sold within 30 days.
  • 349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Chief Investment Officer Hensley Robert Edward sold about $1.1M of GL on Sep 22, 2026; 349 funds added in the latest 13F quarter.
EVP, General Counsel and CRO
SELL
2026-08-10 SECtraded 2026-08-07
11,454
$2.1M
-14.5%
Context
  • 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on May 29, 2026.
  • The trade is 58.7% of the 19,526 shares held after it.
  • 3 other insiders sold within 30 days.
  • 349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, General Counsel and CRO MITCHELL ROBERT BRIAN sold about $2.1M of GL on Aug 7, 2026; 3 other insiders sold within 30 days and 349 funds added in the latest 13F quarter.
EVP, General Counsel and CRO
SELL
2026-08-10 SECtraded 2026-08-07
10,529
$1.9M
-14.5%
Context
  • 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on May 29, 2026.
  • The trade is 117.0% of the 8,997 shares held after it.
  • 3 other insiders sold within 30 days.
  • 349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, General Counsel and CRO MITCHELL ROBERT BRIAN sold about $1.9M of GL on Aug 7, 2026; 3 other insiders sold within 30 days and 349 funds added in the latest 13F quarter.
234 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 229 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$56.5M over 180 days
-$27.7M over 90 days
below 89% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
349 funds bought in last quarter
more than 78% of Insurance
Revenue
+3.7% year over year
below 69% of Insurance
Margin
19.4% net margin
more than 71% of Insurance
Buybacks
$515.2M repurchased, FY to 2026-06-30
more than 79% of Insurance
Short interest
2.8% of the float short (float per yahoo 2026-10-26) · 4.5 days to cover · settled 2026-09-30
more than 50% of Insurance
What changed in the last 30 days
Oct 27EVP & Chief Investment Officer Hensley Robert Edward sold $372.6K (Mar 2)
Oct 26Executive Officer Michael C. Majors filed to sell $2.4M by Oct 23 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 26EVP - Chief Strategy Officer MAJORS MICHAEL CLAY sold $2.2M (Oct 23)

Watch GL

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+14.8%12M
-4%+10%+24%+38%2025-102025-122026-022026-042026-062026-082026-10 2026-07-31 · Darden James Matthew sold $9.0M2025-10-24 · MITCHELL ROBERT BRIAN sold $6.8M2026-07-29 · MAJORS MICHAEL CLAY sold $6.0M2025-10-24 · MITCHELL ROBERT BRIAN sold $5.4M2026-05-22 · SVOBODA FRANK M sold $2.9M2026-03-04 · Darden James Matthew sold $2.7M2026-04-24 · MAJORS MICHAEL CLAY sold $2.7M2026-10-23 · MAJORS MICHAEL CLAY sold $2.2M2026-07-28 · Kalmbach Thomas Peter sold $2.2M2026-05-11 · Kalmbach Thomas Peter sold $2.1M2026-08-07 · MITCHELL ROBERT BRIAN sold $2.1M2026-02-06 · MAJORS MICHAEL CLAY sold $2.0M2026-05-05 · Darden James Matthew sold $2.0M2026-08-07 · MITCHELL ROBERT BRIAN sold $1.9M2026-07-30 · Kalmbach Thomas Peter sold $1.9M2026-05-19 · Kalmbach Thomas Peter sold $1.9M2026-05-05 · SVOBODA FRANK M sold $1.8M2026-04-24 · MAJORS MICHAEL CLAY sold $1.8M2026-05-08 · Kalmbach Thomas Peter sold $1.7M2026-07-28 · Kalmbach Thomas Peter sold $1.7M2026-02-06 · MAJORS MICHAEL CLAY sold $1.7M2026-05-05 · Darden James Matthew sold $1.4M2026-05-01 · SVOBODA FRANK M sold $1.3M2026-02-27 · Haworth Jennifer Allison sold $1.3M2026-05-22 · Kalmbach Thomas Peter sold $1.2M2026-06-11 · SVOBODA FRANK M sold $1.2M2026-09-22 · Hensley Robert Edward sold $1.1M2026-06-12 · SVOBODA FRANK M sold $940.5K2026-02-17 · SVOBODA FRANK M sold $935.1K2026-02-27 · Darden James Matthew sold $932.7K2025-12-16 · SVOBODA FRANK M sold $922.8K2026-07-30 · Kalmbach Thomas Peter sold $871.6K2026-04-24 · MAJORS MICHAEL CLAY sold $789.4K2026-06-12 · SVOBODA FRANK M sold $726.3K2026-04-28 · Darden James Matthew sold $717.5K2026-07-28 · Kalmbach Thomas Peter sold $681.2K2026-03-31 · Zorn Rebecca E sold $645.8K2026-07-29 · MAJORS MICHAEL CLAY sold $627.7K2026-02-12 · Haworth Jennifer Allison sold $614.8K2026-02-12 · Haworth Jennifer Allison sold $590.1K2026-09-22 · Hensley Robert Edward sold $566.9K2026-02-17 · SVOBODA FRANK M sold $517.5K2026-10-26 · Michael C. Majors filed to sell $2.4M2026-09-22 · Robert E. Hensley filed to sell $1.7M2026-08-13 · Frank M. Svoboda filed to sell $2.9M2026-08-05 · MITCHELL ROBERT BRIAN filed to sell $4.2M2026-07-29 · James Matt Darden filed to sell $9.0M2026-07-27 · Thomas Kalmbach filed to sell $8.1M2026-07-24 · Michael C. Majors filed to sell $6.3M2026-06-30 · Dolores Skarjune filed to sell $331.7K2026-06-18 · Rebecca E. Zorn filed to sell $338.3K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns GL: institutional holders (13F)

13F holdings, latest reported quarter
5,528,883 sh
$987.9M
4,619,219 sh
$825.4M
3,735,409 sh
$667.4M

Congress trades in GL

STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-07-10 · disclosed 34 days later
$1,001 - $15,000
Bought 2025-06-17 · disclosed 57 days later
$1,001 - $15,000

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

GL planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Michael C. Majors
Filed 2026-10-26
$2.4M
Robert E. Hensley
Filed 2026-09-22
$1.7M
Frank M. Svoboda
Filed 2026-08-13
$2.9M
MITCHELL ROBERT BRIAN
Filed 2026-08-05
$4.2M
James Matt Darden
Filed 2026-07-29
$9.0M

GL mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Victory RS Investors Fund
$4.7M position · as of 2026-06-30
6.7%
SEGALL BRYANT & HAMILL SELECT EQUITY ETF
$16.2M position · as of 2026-06-30
4.5%
Victory RS Value Fund
$11.2M position · as of 2026-06-30
4.4%
Victory RS Partners Fund
$23.6M position · as of 2026-06-30
3.5%
Hartford Global Impact Fund
$10.8M position · as of 2026-07-31
3.0%
SBH GLOBAL ALL CAP FUND
$1.0M position · as of 2026-06-30
2.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Globe Life Inc. Pac
Cycle 2026 · $69K spent
$86.7K
Federal Election Commission, matched by the PAC's connected organisation
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $56.5M sold by insiders over 180 days, 349 funds added last quarter, $20.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

GL financials

Revenue growth
+3.7%
XBRL, annual
Net margin
19.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.2B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+19.6%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$1.2B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.48x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
0.47x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+20.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+4.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+12.8%
operating income after a 18.9% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
n/a
assets or current liabilities not filed
P/E, trailing
10.27x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no cash line filed
FCF yield
+10.4%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
0.50x
P/E over trailing EPS growth of 20%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$6.0B$5.8B$5.4B$5.2B
Gross profitn/an/a$1.3B$1.2B
Operating incomen/an/a$1.3B$1.2B
Net income$1.2B$1.1B$970.8M$894.4M
EPS (diluted)14.0711.9410.079.04
Operating cash flow$1.4B$1.4B$1.5B$1.4B
Long-term debt$2.3B$2.3B$1.6B$1.6B
Buybacks$881.0M$1.0B$511.1M$454.6M
Dividends paid$86.1M$85.5M$84.1M$80.5M
SEC XBRL, fiscal years, as known on 2026-10-27

GL Stock Sonar score 6/7 axes

Find similar shapesCompare

GL ranks highest on profitability (61st percentile) and risk and compliance (58th), and lowest on insider conviction (5th), among Insurance peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
61
Inputs
  • Return on equity+20.9% · 71 pct, sector of 116
  • Return on assets+4.0% · 59 pct, sector of 122
  • Return on invested capital+12.8% · 54 pct, universe of 1,069
  • Return on capital employedassets or current liabilities not filed
Financial health
36
Inputs
  • Debt to equity0.48x · 28 pct, sector of 104
  • Cash flow to debt0.47x · 44 pct, sector of 97
Growth
31
Inputs
  • Revenue growth, YoY+3.7% · 31 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
5
Inputs
  • Net Form 4 buying (codes P and S), 180d-$56.5M · 9 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
53
Inputs
  • Funds adding, latest quarter349 · 78 pct, sector of 108
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$240K · 29 pct, sector of 35
Risk and compliance
58
Inputs
  • Short interest, % of float+2.8% · 63 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+9.9% · 54 pct, sector of 110
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

GL filings, in plain words

Are Globe Life insiders buying or selling GL?

In the 180 days to 2026-10-27, Globe Life insiders were net sellers, a net $56.5M across purchases and sales reported on Form 4, by 10 sellers.

Have members of Congress traded GL?

Yes, but not in the year to 2026-10-27; the latest on record is a sale by Lisa McClain dated 2025-07-10.

Are there planned insider sales of GL?

Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $20.3M of stock; the latest, by Michael C. Majors, was filed 2026-10-26.

Read the full summary

In the 180 days to 2026-10-27, Globe Life insiders were net sellers of GL, a net $56.5M across purchases and sales reported on Form 4 by 10 sellers. None of the 49 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in GL, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-07-10. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $20.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing